Accelerate Drug Development with Multiscale Simulations

The pharmaceutical industry needs to accelerate time-to-market efficiently. For oligonucleotide therapeutics, multiscale computational chemistry simulations, combined with digital twin technology, offer a powerful solution. This approach allows for modeling, predicting, and optimizing every stage of formulation, from initial design to manufacturing, significantly reducing the need for extensive experimental testing. Ultimately, this digital strategy fosters rapid, innovative, and sustainable drug development in a highly regulated environment.